41 results on '"Schmees, Christian"'
Search Results
2. Functionally-instructed modifiers of response to ATR inhibition in experimental glioma
3. Patientenabgeleitete Mikrotumoren: Eine Möglichkeit der Vorhersage des medikamentösen Therapieansprechens – ein Fallbericht
4. Breast cancer patient-derived microtumors resemble tumor heterogeneity and enable protein-based stratification and functional validation of individualized drug treatment
5. Abstract 44: An in vivo platform of pre-characterized renal cell carcinoma (RCC) patient-derived xenograft models allows the preclinical evaluation of patient-tailored intervention strategies
6. Generation and characterization of three induced pluripotent stem cells lines from an 86-year old female individual diagnosed with an invasive lobular mammary carcinoma
7. Co-cultures of iPSC-derived Mammary-like Organoids and Patient-derived Microtumors Model Invasive Behavior of Breast Cancer ex vivo
8. Establishment of Four Induced Pluripotent Stem Cell Lines from CD34+ Hematopoietic Stem and Progenitor Cells from a Patient Diagnosed with an Invasive Lobular Mammary Carcinoma
9. Protein Profiling of Breast Carcinomas Reveals Expression of Immune-Suppressive Factors and Signatures Relevant for Patient Outcome
10. A platform of patient-derived microtumors identifies individual treatment responses and therapeutic vulnerabilities in ovarian cancer
11. A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies
12. A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer
13. Patientenabgeleitete Mikrotumoren
14. Protein profiling of breast carcinomas reveals expression of immune-suppressive factors and signatures relevant to patient outcome
15. Nicotinamide‐N‐methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma
16. Continuous, non-invasive monitoring of oxygen consumption in a parallelized microfluidic in vitro system provides novel insight into the response to nutrients and drugs of primary human hepatocytes
17. A platform of patient-derived microtumors identifies therapeutic vulnerabilities in ovarian cancer
18. EXTH-48. NOVEL COMBINATION THERAPY IN PRECLINICAL GLIOMA MODELS USING THE CELL CYCLE STABILIZING COMPOUND ARGYRIN F AND CHECKPOINT INHIBITION
19. TAMI-34. TARGETING CSF1R AND PD1 IN EXPERIMENTAL GLIOMA
20. Parallelizable Microfluidic Platform to Model and Assess In Vitro Cellular Barriers: Technology and Application to Study the Interaction of 3D Tumor Spheroids with Cellular Barriers
21. Enhancing preclinical predictivity: what is going wrong between preclinical in vitro/in vivo and clinical in vivo settings?
22. Advancement of precision oncology by integration of highly sensitive protein profiling technologies and patient-derived cell models for functional efficacy testing
23. Generation and characterization of the human induced pluripotent stem cell line NMIi010-A from peripheral blood mononuclear cells of a healthy 49–year old male individual
24. Argyrin F Treatment‐Induced Vulnerabilities Lead to a Novel Combination Therapy in Experimental Glioma
25. Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma
26. Abstract PS17-42: A fast and effective 3D preclinical assay system comprised of patient derived breast cancer microtumors combined with DigiWest protein signaling pathway analyses for therapeutic response prediction (Project PRIMO)
27. HepaChip-MP – a twenty-four chamber microplate for a continuously perfused liver coculture model
28. VacA-Associated Inhibition of T-cell Function: Reviewed and Reconsidered
29. A peptide tag-specific nanobody enables high-quality labeling for dSTORM imaging
30. Abstract 1843: Intratumoral heterogeneity of renal cancer is related to differences in drug response and development of therapy resistance
31. A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts
32. MP99-09 PROSTATE CANCER GENOMICS – IDENTIFICATION OF PROGNOSTIC MARKERS FROM THE BONE MARROW
33. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer
34. Live imaging of endogenous protein dynamics in zebrafish using chromobodies
35. Abstract 1192: Establishment and characterization of a new patient-derived renal cell carcinoma xenograft panel
36. Hemmung der Proliferation von T-Lymphozyten durch Helicobacter pylori als Mechanismus der Immunevasion
37. Activation of Protein Kinase C α Is Necessary for Sorting the PDGF β-Receptor to Rab4a-dependent Recycling
38. Inhibition of T-Cell Proliferation by Helicobacter pylori γ-Glutamyl Transpeptidase
39. A Secreted Low--Molecular-Weight Protein From Helicobacter pylori Induces Cell-Cycle Arrest of T Cells
40. Activation of protein kinase C alpha is necessary for sorting the PDGF beta-receptor to Rab4a-dependent recycling.
41. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.